Future of Herpes Simplex Virus Infection Treatments Reviewed in a New Study
Herpes simplex virus infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. The period of latency and mode of reactivation of HSV is still unclear. According to prevalence statistics published by the Centers for Disease Control and Prevention (CDC), HSV-2 prevalence was over 16% among the population of the U.S. and primarily affected African-American women. The Public Health Agency of Canada indicated that prevalence of HSV-1 infection is greater than HSV-2 infections in most of regions. Various publications also show that prevalence of HSV is higher in low and middle income countries. Hence, prevalence of herpes simplex virus is expected to be high in countries in Africa. Due to underdeveloped economic conditions, demand for cost-effective diagnostic tests is high.
Rise in prevalence of HSV infection, increase in rate of new infections, and continuous mutations in the microorganisms leading to new strains are factors driving the global herpes simplex virus infection treatments market. Furthermore, increase in modes of transmission of the infectious disease and lack of cleanliness in developing regions has propelled the herpes simplex virus infection treatments market. According to the WHO, more women are infected with HSV-2 than men. In 2012, an estimated 267 million women and 150 million men were living with the infection.
The global herpes simplex virus infection treatments market can be segmented based on virus type, route of administration, drug molecule, distribution channel, and region. In terms of type of virus, the global market can be categorized into herpes simplex virus-1 (HSV-1) infection, herpes simplex virus-2 (HSV-2) infection, and HSV1 & HSV2 co-infection. Based on route of administration, the global herpes simplex virus infection treatments market can be bifurcated into oral and parenteral. In terms of drug molecule, the global market can be divided into small molecule, vaccines, and others. Based on distribution channel, the global herpes simplex virus infection treatments market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment accounted for considerable share of the herpes simplex virus infection treatments market due to availability of generic drugs. The online pharmacies segment is expected to grow at a rapid pace in the near future due to rise in adoption of online purchases in developed countries such as the U.S.
Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/herpes-simplex-virus-infection-treatments-market.html
Geographically, the global herpes simplex virus infection treatments market can be segmented into five major regions: North America (U.S., and Canada), Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Mexico, Brazil, and Rest of Latin America), and Middle East & Africa (Saudi Arabia, South Africa, Israel, and Rest of Middle East and Africa). Prevalence of herpes simplex virus infection is higher in Asia Pacific and Middle East & Africa than in North America and Europe. According to statistics published by World Health Organization in 2012, an estimated 3.7 billion people under the age of 50, or 67% of the population, had HSV-1 infection globally. Estimated prevalence of the infection was the highest in countries in Africa (87%) and lowest in the Americas (40% to 50%).
Key players developing herpes simplex virus infection treatments market are GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Agenus, Inc., Maruho Co. Ltd., Sanofi Pasteur SA., Chimerix, Admedus, and AiCuris Anti-infective Cures GmbH.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis
Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=58977&source=atm
The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=58977&source=atm